Millipede is developing a percutaneous solution for mitral valve repair.
Millipede develops a catheter-based solution to treat mitral and tricuspid regurgitation, restoring health and expanding options for physicians, and global patients.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 24, 2018 | Series Unknown | $43.17M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Boston Scientific | — | Series Unknown |